The womb itself ages in ways that matter, independent of egg quality.
For generations, reproductive medicine held that the aging of eggs was the primary barrier to late-life fertility—and that younger donor eggs could, in effect, turn back the clock. A study of nearly 1,800 women, led by Dr. Beatrice Crestani in Italy, now reveals that the womb itself ages in ways that matter: women over 49 face meaningfully lower success rates and nearly double the miscarriage risk even when using eggs from young donors. The finding does not foreclose hope, but it asks medicine—and the women it serves—to hold a more honest reckoning with the body's own timeline.
- A cornerstone assumption of fertility medicine—that donor eggs fully reset reproductive aging—has been directly challenged by new clinical evidence.
- Women over 49 face a pregnancy success rate of 43% with donor eggs compared to 54% for women aged 35–40, and their miscarriage risk nearly doubles to 38%.
- The womb lining itself, not just egg quality, appears to deteriorate with age, pointing to an entirely new biological frontier that current treatments cannot yet address.
- Researchers believe womb aging may eventually be measurable and treatable, but for now, clinics are being urged to counsel older patients with far greater candor about realistic outcomes.
- Women like Sharon Marshall, who endured six years, seven IVF rounds, and two miscarriages before giving birth at 46, put a human face on what the statistics quietly describe: years of physical toll, depression, and suspended life.
A study of nearly 1,800 women has challenged one of fertility medicine's most enduring assumptions: that using younger donor eggs can fully restore a woman's reproductive potential regardless of age. Led by Dr. Beatrice Crestani at an assisted reproduction institute in Italy, the research found that women aged 49 and older experience a significant drop in treatment success even when eggs come from much younger donors. Pregnancy rates fall from 54% for women in their mid-to-late 30s to 43% for those 49 or older. Live birth rates decline from 46% to 32%, and miscarriage risk nearly doubles.
The explanation, researchers believe, lies not in the eggs but in the womb itself. Age-related changes in the endometrium—the lining where an embryo implants—appear to worsen over time even as its thickness remains similar across age groups. This suggests the womb has its own aging process, independent of egg quality, that donor eggs cannot override.
The findings are not a counsel of despair. Among women 49 and older who transferred all available embryos, the live birth rate still reached 62.5%—lower than the roughly 80% seen in younger women, but far from negligible. Crestani stresses that older women should not be discouraged from pursuing treatment, but that they deserve honest guidance about what donor eggs can and cannot do. Future research may eventually identify biomarkers of uterine aging or develop treatments to improve womb health directly.
The human weight of these findings is carried by women like Sharon Marshall, a television personality who spent six years pursuing IVF in her 40s, endured two miscarriages and seven rounds of treatment, and gave birth to her daughter at 46. She describes those years as marked by illness, depression, and a loss of control over her own body—and she calls for the kind of honesty this research now makes harder to avoid. In the UK, there is no legal upper age limit for IVF, though NHS funding typically covers women only up to 42. The new evidence adds urgency to calls for thorough counseling and careful clinical assessment before older women begin treatment.
A study of nearly 1,800 women has upended a long-held assumption in fertility medicine: that using younger donor eggs can fully restore a woman's reproductive potential, no matter her age. The research, led by Dr. Beatrice Crestani at an assisted reproduction institute in Italy, found that women aged 49 and older face a marked decline in fertility treatment success—even when the eggs themselves come from much younger donors. The pregnancy rate drops from 54 percent for women in their mid to late 30s to just 43 percent for those 49 or older. Live birth rates fall from 46 percent to 32 percent. And the risk of miscarriage nearly doubles, climbing from 24 percent to 38 percent.
For decades, reproductive medicine has treated aging as primarily an ovarian problem. The logic was straightforward: replace the aging eggs with fresh ones from a younger woman, and you reset the clock. But Crestani's findings suggest the picture is far more complicated. The researchers observed age-related changes in the endometrium—the womb lining where an embryo implants and develops—in the older women. While the thickness remained similar across age groups, the condition of the lining itself deteriorated with time. This suggests that the womb itself ages in ways that matter, independent of egg quality.
The implications are significant but not catastrophic. Even at advanced ages, success rates remain meaningful. Among women aged 35 to 40 who transferred all available embryos, the live birth rate reached around 80 percent. For those 49 or older, it was 62.5 percent—substantially lower, but far from impossible. Crestani emphasizes that these findings should not discourage older women from pursuing donor-egg treatment. But she adds a crucial caveat: patients need to understand that donor eggs cannot completely erase the effects of reproductive aging, particularly beyond 49.
The research also points toward future possibilities. If age-related changes in the womb lining are indeed the culprit, they may be treatable. Researchers believe it might eventually be possible to predict, prevent, or improve womb age itself—opening a new frontier in fertility medicine beyond simply replacing eggs. The work is being presented at the European Society of Human Reproduction and Embryology and published in a medical journal. Prof. Borut Kovacic, chair-elect of ESHRE, notes that while the study identifies an age threshold where uterine function begins to decline, it is unlikely to be absolute. The findings, he says, provide a foundation for future research into biomarkers of uterine aging.
But the human dimension of this research extends beyond the science. Sharon Marshall, a television personality who spent six years pursuing IVF in her 40s, gave birth to her daughter at 46 after seven rounds of treatment and two miscarriages. She describes those years as a blur of illness, depression, and lost autonomy over her own body. She had made a pact with herself to stop at 47 if it didn't work. Throughout her pregnancy, she never felt calm until the moment her daughter was born. Speaking to the new findings, Marshall argues for honesty: "Let's be honest with women about the difficulties they may face, about how hard it can be to get pregnant when you get older. We deserve to know that."
In the United Kingdom, there is no legal upper age limit for IVF, though some European countries impose cutoffs—Greece, for instance, stops at 54. Women in the UK can donate eggs only up to age 36. The NHS recommends three cycles of IVF for women up to 40 and one cycle for those up to 42, though these are funded treatments. Donor-egg cycles typically require private payment. Regulators ask private clinics to assess both the welfare of any resulting child and the physical ability of the recipient to carry a pregnancy safely. Dr. Ippokratis Sarris, chair-elect of the British Fertility Society, recommends more research and emphasizes that pregnancies can be riskier for older women, making thorough checks and counseling essential before treatment begins.
The research does not close the door on fertility treatment for older women. Rather, it opens it more carefully, with clearer sight lines to what lies ahead. The womb, it turns out, has its own timeline—one that cannot be entirely overridden by the freshness of an egg.
Citas Notables
Our findings suggest the picture is more complex. Donor eggs cannot completely eliminate the effects of reproductive ageing, particularly beyond 49 years.— Dr. Beatrice Crestani, lead researcher
Let's be honest with women about the difficulties they may face, about how hard it can be to get pregnant when you get older. We deserve to know that.— Sharon Marshall, television personality and IVF patient
La Conversación del Hearth Otra perspectiva de la historia
So the study is saying that using a young egg doesn't solve the aging problem entirely. Why would that surprise anyone? Isn't it obvious that the whole body ages?
It would seem obvious, but fertility medicine had largely settled on a different story. The thinking was: eggs are the limiting factor. Replace the egg, reset the system. It's a clean narrative, and it's been driving treatment for years. This research suggests the womb itself is aging in ways that matter independently.
And they found this by looking at what, exactly? The thickness of the lining?
They measured thickness, but that wasn't the key finding. The thickness stayed relatively consistent across age groups. What changed was the condition of the lining itself—its quality, its receptiveness. It's subtle, but it's real, and it gets worse with age.
The numbers are pretty stark. Pregnancy rates drop from 54 percent to 43 percent. That's not a small difference.
No. And the miscarriage rate nearly doubles. But here's what matters: 43 percent is still a meaningful chance. The researchers are careful to say this shouldn't discourage older women. It's just that the conversation needs to be honest about what's actually possible.
Sharon Marshall's story is pretty brutal—six years, seven rounds, two miscarriages. Was that typical?
There's no typical in fertility treatment, but her experience of years of physical strain, depression, and loss of control is something many women report. The emotional and bodily toll accumulates. She had to make a deal with herself just to know when to stop.
What happens next? Can they actually treat womb aging?
That's the frontier. If the problem is the lining itself, not the egg, then theoretically you could develop treatments to improve it. They're talking about biomarkers, ways to predict and prevent decline. It's early, but it's a different kind of hope than just finding younger eggs.